EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effects of postoperative glucocorticoids on mitigation of organ dysfunction in patients with type A aortic dissection: a randomized controlled trial

Ming-Hao Luo, Jing-Chao Luo, Xin Xu, Zhen-Hua He, Yin-Rui Huang, Chen Chen, Ying Su, Jun-Yi Hou, Chun-Sheng Wang, Hao Lai, Guo-Wei Tu, Zhe Luo iD

European Journal of Cardio-Thoracic Surgery · 2024

DOI: 10.1093/ejcts/ezae441 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2024. Verfasst von Ming-Hao Luo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Intensive Care Center, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Aortic Dissection, Glucocorticoids, Methylprednisolone. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Research Project of Shanghai Municipal Health Commission, Science and Technology of Shanghai Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES This study aims to evaluate the organ-protective efficacy of postoperative glucocorticoid in patients with type A aortic dissection. METHODS Postoperative type A aortic dissection patients were randomly allocated to receive either postoperative glucocorticoid or standard-of-care treatment. Intravenous methylprednisolone was administered for 3 days. The primary outcome was the reduction of Sequential Organ Failure Assessment score on postoperative day 4 compared to baseline (on postoperative day 1 before methylprednisolone administration). RESULTS Two hundred twelve patients were included in the intention-to-treat analysis. The primary outcome was significantly different between groups: 3.16 ± 2.52 in the control group versus 4.36 ± 2.82 in the glucocorticoid group (absolute difference 1.20 [95% CI 0.52–1.93], P = 0.001). The glucocorticoid group showed markedly lower median high-sensitivity C-reactive protein levels compared to the control group (91.0 mg/l vs 182.0 mg/l; absolute difference: –91 (95% CI –122 to –57), P = 0.009) on postoperative day 4. Fewer patients in the glucocorticoid group required continuous renal replacement therapy (8.5% vs 19.8% in the control group; absolute difference: –10.4 [95% CI –19.1 to –1.3], P = 0.03). CONCLUSIONS This trial demonstrates that postoperative glucocorticoid in patients with type A aortic dissection significantly reduces postoperative inflammation and improves recovery of early organ dysfunction. These findings advocate for the implementation of glucocorticoid in the early phase after surgery for enhanced organ protection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic DissectionGlucocorticoidsMethylprednisoloneHumansMaleFemaleMiddle AgedPostoperative ComplicationsAgedPostoperative CareAortic AneurysmMultiple Organ FailureTreatment Outcome

Stichwörter der Autor:innen

Aortic dissectionGlucocorticoidsInflammationOrgan dysfunction

Substanzen

GlucocorticoidsMethylprednisolone

Autor:innen und Institutionen

  • Cardiac Intensive Care Center, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Shanghai Medical College, Fudan University, Shanghai, China.
  • Department of Critical Care Medicine, Pan Long People's Hospital, Kunming, Yunnan, China.
  • Department of Critical Care Medicine, Dehong Prefecture People's Hospital, Dehong Dai and Jingpo Autonomous Prefecture, Yunnan, China.
  • Department of Critical Care Medicine, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.
  • Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.

ORCID-Profile: Zhe Luo

Förderung

  • National Natural Science Foundation of China
  • Research Project of Shanghai Municipal Health Commission
  • Science and Technology of Shanghai Committee

Zitieren

APA

Luo, M. H., Luo, J. C., Xu, X., He, Z. H., Huang, Y. R., Chen, C., Su, Y., Hou, J. Y., Wang, C. S., Lai, H., Tu, G. W., & Luo, Z. (2024). Effects of postoperative glucocorticoids on mitigation of organ dysfunction in patients with type A aortic dissection: a randomized controlled trial. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezae441

Vancouver

Luo MH, Luo JC, Xu X, He ZH, Huang YR, Chen C, et al. Effects of postoperative glucocorticoids on mitigation of organ dysfunction in patients with type A aortic dissection: a randomized controlled trial. European Journal of Cardio-Thoracic Surgery. 2024. doi:10.1093/ejcts/ezae441

BibTeX
@article{Luo2024,
  author = {Luo, Ming-Hao and Luo, Jing-Chao and Xu, Xin and He, Zhen-Hua and Huang, Yin-Rui and Chen, Chen and Su, Ying and Hou, Jun-Yi and Wang, Chun-Sheng and Lai, Hao and Tu, Guo-Wei and Luo, Zhe},
  title = {Effects of postoperative glucocorticoids on mitigation of organ dysfunction in patients with type A aortic dissection: a randomized controlled trial},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2024},
  doi = {10.1093/ejcts/ezae441}
}
Kostenlos starten →